Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Oct 28, 2018; 24(40): 4586-4595
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4586
Figure 1
Figure 1 Study inclusion flowchart. HIV: Human immunodeficiency virus; SPM: Second primary malignancy.
Figure 2
Figure 2 Competing-risk model plot for cumulative incidence of death and secondary primary malignancy, stratified by with/without radiotherapy. SPM: Secondary primary malignancy; RT: Radiotherapy.
Figure 3
Figure 3 Secondary cancer site analysis for (A) with/without radiotherapy, and (B) preoperative and postoperative radiotherapy. Referenced by surgery-alone group, aP < 0.05; HR: Hazard ratio; NA: Not applicable.